Back
  1. Home
  2. Profile of Anne Trelcat (UMONS)
Profil

Trelcat Anne

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service d'Anatomie humaine et Oncologie expérimentale

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service de Chirurgie

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service de Cardiologie

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Anatomie humaine et Oncologie expérimentale

Main Referenced Co-authors
JOURNE, Fabrice  (11)
SAUSSEZ, Sven  (8)
CARLIER, Stéphane  (6)
Kindt, Nadège (5)
Scalia, Alessandro  (5)
Main Referenced Keywords
Molecular Biology (3); oxLDL (3); atherosclerosis (2); Cancer Research (2); head and neck cancer (2);
Main Referenced Disciplines
Oncology (8)
Cardiovascular & respiratory systems (5)
Chemistry (2)
Pharmacy, pharmacology & toxicology (1)
Anatomy (cytology, histology, embryology...) & physiology (1)

Publications (total 14)

The most downloaded
57 downloads
Kindt, N., Journe, F., Carlier, S., Trelcat, A., Scalia, A., & Saussez, S. (05 May 2021). Effect of Oxidized Low-Density Lipoprotein on Head and Neck Squamous Cell Carcinomas. Biomedicines, 9 ((5)), 513. https://hdl.handle.net/20.500.12907/30991

The most cited

45 citations (Scopus®)

Descamps, G., Verset, L., Trelcat, A., Hopkins, C., Lechien, J., Journe, F., & Saussez, S. (2020). ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection. Biology. https://hdl.handle.net/20.500.12907/11166

Scalia, A., Coquay, M., Kindt, N., DUEZ, P., Aro, R., JOURNE, F., Fabjanczyk, M., Trelcat, A., & CARLIER, S. (31 August 2024). In Vitro Modulation of Human Foam Cell Formation and Adhesion Molecules Expression by Ginger Extracts Points to Potential Cardiovascular Preventive Agents. International Journal of Molecular Sciences, 25 (17), 9487. doi:10.3390/ijms25179487
Peer Reviewed verified by ORBi

Mhaidly, N., Barake, N., Trelcat, A., JOURNE, F., SAUSSEZ, S., & DESCAMPS, G. (01 August 2024). Bufalin Suppresses Head and Neck Cancer Development by Modulating Immune Responses and Targeting the β-Catenin Signaling Pathway. Cancers, 16 (15), 2739. doi:10.3390/cancers16152739
Peer Reviewed verified by ORBi

Kindt, N., Thayse, K., Dalil, N., Trelcat, A., & Carlier, S. (May 2024). Does female sex matter in a chronic intermittent hypoxia mouse model? Journal of Molecular and Cellular Cardiology, 190, 76 - 78. doi:10.1016/j.yjmcc.2024.04.005
Peer Reviewed verified by ORBi

Soumoy, L., Genbauffe, A., Mouchart, L., Sperone, A., Trelcat, A., Mukeba-Harchies, L., Wells, M., Blankert, B., Najem, A., Ghanem, G., Saussez, S., & Journe, F. (04 January 2024). ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy. Cancer Cell International, 24 (1), 8. doi:10.1186/s12935-023-03196-y
Peer Reviewed verified by ORBi

Mhaidly, N., Journe, F., Najem, A., Stock, L., Trelcat, A., Dequanter, D., SAUSSEZ, S., & DESCAMPS, G. (15 August 2023). Macrophage Profiling in Head and Neck Cancer to Improve Patient Prognosis and Assessment of Cancer Cell-Macrophage Interactions Using Three-Dimensional Coculture Models. International Journal of Molecular Sciences, 24 (16), 12813. doi:10.3390/ijms241612813
Peer Reviewed verified by ORBi

Scalia, A., Doumani, L., Kindt, N., Journe, F., Trelcat, A., & Carlier, S. (22 June 2023). The Interplay between Atherosclerosis and Cancer: Breast Cancer Cells Increase the Expression of Endothelial Cell Adhesion Markers. Biology, 12 (7), 896. doi:10.3390/biology12070896
Peer Reviewed verified by ORBi

Scalia, A., Kindt, N., Trelcat, A., Nachtergael, A., Duez, P., Journe, F., & Carlier, S. (19 October 2022). Development of a Method for Producing oxLDL: Characterization of Their Effects on HPV-Positive Head and Neck Cancer Cells. International Journal of Molecular Sciences, 23 (20), 12552. doi:10.3390/ijms232012552
Peer Reviewed verified by ORBi

Scalia, A., Kindt, N., Trelcat, A., Nachtergael, A., Duez, P., & Carlier, S. (10 February 2022). Development of 'home-made' oxLDL to study the interplay between atherosclerosis and cancer: characterization of their effects on head and neck cancer cells [Paper presentation]. Belgian Society of Cardiology Meeting, Bruxelles, Belgium.

Kindt, N., Journe, F., Carlier, S., Trelcat, A., Scalia, A., & Saussez, S. (05 May 2021). Effect of Oxidized Low-Density Lipoprotein on Head and Neck Squamous Cell Carcinomas. Biomedicines, 9 ((5)), 513.
Peer Reviewed verified by ORBi

Gheysen, L., Soumoy, L., Trelcat, A., Verset, L., Journe, F., & Saussez, S. (2021). New Treatment Strategy Targeting Galectin-1 against Thyroid Cancer. Cells.
Peer Reviewed verified by ORBi

Descamps, G., Verset, L., Trelcat, A., Hopkins, C., Lechien, J., Journe, F., & Saussez, S. (2020). ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection. Biology.
Peer Reviewed verified by ORBi

Soumoy, L., Trelcat, A., Schepkens, C., Tagliatti, V., Ghanem, G., Saussez, S., & Journe, F. (31 January 2020). Metabolic switch in melanoma cells with acquired resistance to targeted therapies [Poster presentation]. BACR Annual meeting, Jette, Belgium.

Soumoy, L., Trelcat, A., Schepkens, C., Tagliatti, V., Ghanem, G., Saussez, S., & Journe, F. (31 January 2020). Metabolic switch in melanoma cells with acquired resistance to targeted therapies [Poster presentation]. 14th meeting of the FRS-FNRS Contact group on Oxidative Proceses and Antioxidants, UMONS, Belgium.

Gheysen, L., Descamps, G., Seminerio, I., Furgiuele, S., Soumoy, L., & Trelcat, A. (2019). Wonder Researchers , Communication audiovisuelle, Journée des doctorants, Mons, 2019.

Contact ORBi UMONS